VM
This company develops renal denervation devices that lower systolic blood pressure by reducing sympathetic nerve activity in the kidneys. Their technology offers a minimally invasive approach to managing hypertension and reducing the risk of cardiovascular events.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops renal denervation devices that lower systolic blood pressure by reducing sympathetic nerve activity in the kidneys. Their technology offers a minimally invasive approach to managing hypertension and reducing the risk of cardiovascular events.